MedPath

Effect of Yogurt Fortified with beta-Hydroxy beta-Methyl Butyrate (HMB) in Sarcopenic Elderly

Phase 2
Conditions
M62.84
Sarcopenia.
Sarcopenia
Registration Number
IRCT20171223038017N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Men and women aged 65 years and older
Sarcopenia diagnosis according to European Working Group on Sarcopenia in Older People (EWGSOP) guidelines

Exclusion Criteria

Subjects unable to move without crutches, walker or other assistive devices.
Subjects with artificial limbs.
Subjects with history of chronic disease (e.g. Congestive Heart Failure (CHF), Chronic Obstructive Pulmonary Disorder (COPD), Chronic Renal Failure (CRF), cirrhosis liver failure and active cancer).
Subjects with history of kidney stones.
Subjects who regularly consume any medications interfering with nutritional intervention (e.g. steroids, heparin, free amino acid, antioxidant, omega-3, vitamin D supplements).

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fat-free mass. Timepoint: Before and after intervention. Method of measurement: Dual energy X-ray Absorptiometry (DXA); Bioelectrical Impedance Analysis (BIA).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath